<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1453">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04403880</url>
  </required_header>
  <id_info>
    <org_study_id>HVTN 405/HPTN 1901</org_study_id>
    <secondary_id>5UM1AI068614-14</secondary_id>
    <nct_id>NCT04403880</nct_id>
  </id_info>
  <brief_title>Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19</brief_title>
  <official_title>Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HIV Vaccine Trials Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>HIV Prevention Trials Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>HIV Vaccine Trials Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn more about infection with and recovery from the virus
      called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people know this
      virus by the name &quot;coronavirus.&quot; It can cause the disease called COVID-19.

      The information gained from the study will be used to help develop better tests for
      SARS-CoV-2 infection and COVID-19 disease and may help in developing future vaccines and
      treatments by allowing researchers to determine the difference between the body's immune
      response to natural SARS-CoV-2 infection and immunization with a SARS-CoV-2 vaccine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to characterize the SARS-CoV-2-specific immunity in convalescent individuals.

      The observational cohort study will include 3 groups, as described in the table below.

      Participants will complete a minimum of one visit (1-8 weeks post resolution of COVID-19 OR
      2-10 weeks post most recent positive SARS-CoV-2 test, if asymptomatic) and optional visits
      approximately 2 months, 4 months, and 1 year later. Participants diagnosed with SARS-CoV-2
      infection at an optional follow-up visit may be contacted more frequently. Additional follow
      up visit(s) may be added over time in response to evolving information regarding SARS-CoV-2
      infection and COVID-19.

      Study visits may include physical examinations, medical history, questionnaires, pregnancy
      tests (for participants assigned female at birth), blood draws, optional nasal samples, and
      optional HIV testing.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 13, 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Humoral responses to peptide antigens derived from SARS-CoV-2 structural proteins and regions of the spike protein not present in vaccines</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by peptide microarray</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific antibody binding response rate</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific antibody binding response magnitude</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific antibody binding response epitope specificity</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific antibody neutralization response rate</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by neutralizing antibody assay (NAb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific antibody neutralization response magnitude</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by neutralizing antibody assay (NAb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific antibody neutralization response epitope specificity</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by neutralizing antibody assay (NAb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific Antibody-Dependent Cellular Cytotoxicity (ADCC) response rate</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by antibody-dependent cellular cytotoxicity assay (ADCC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific Antibody-Dependent Cellular Cytotoxicity (ADCC) response magnitude</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by antibody-dependent cellular cytotoxicity assay (ADCC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific Antibody-Dependent Cellular Cytotoxicity (ADCC) response epitope specificity</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by antibody-dependent cellular cytotoxicity assay (ADCC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific CD4+ and CD8+ T cell responses</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by flow cytometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific CD4+ and CD8+ T cell response rate</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by flow cytometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific CD4+ and CD8+ T cell response magnitude</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by flow cytometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific CD4+ and CD8+ T cell response functional profiling</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by flow cytometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific memory B cell characterization</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by phenotyping and monoclonal antibody isolation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SARS-CoV-2-specific infection presentation, including clinical course, along with demographics and corresponding medical history of participants</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Tabulated overall and by group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of viral RNA in nasopharyngeal or nasal swab samples</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by real-time reverse transcription polymerase chain reaction (RT-PCR) assay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response rate of SARS-CoV-2-specific binding antibodies in nasal samples</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response magnitude of SARS-CoV-2-specific binding antibodies in nasal samples</measure>
    <time_frame>Measured through participant's last visit at Month 0, 2, 4, or 12</time_frame>
    <description>Measured by binding antibody multiplex assay (BAMA)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">727</enrollment>
  <condition>SARS-CoV-2</condition>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Persons not hospitalized for COVID-19, without clinical spectrum or outcomes specified in group 3
1A: Persons with asymptomatic infection, ages 18 through 55, inclusive
1B: Persons with asymptomatic infection, age &gt; 55
1C: Persons with symptomatic infection (ie, COVID-19) ages 18 through 55
1D: Persons with symptomatic infection (ie, COVID-19), age &gt; 55</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Persons previously hospitalized for COVID-19, without clinical spectrum or outcomes specified in group 3
2A: Persons 18 through 55 years of age
2B: Persons &gt; 55 years of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Persons with specific clinical spectrums or outcomes, regardless of hospitalization history (eg, persons recovered after intubation, with prolonged viral shedding, with myocarditis/pericarditis, with rapid recovery from COVID-19, with a second positive SARS-CoV-2 RT-PCR test result after a negative result)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sample collection</intervention_name>
    <description>Optional nasal specimen(s)
Blood collection</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Persons reporting a positive test for SARS-CoV-2 and resolution of COVID-19 within 1-8
        weeks of enrollment OR, if asymptomatic infection, reporting positive SARS-CoV-2 test
        within 2-10 weeks of enrollment.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older.

          -  Reports having had a positive test for SARS-CoV-2.

          -  Reports resolution of COVID-19 within 1-8 weeks of enrollment OR, if asymptomatic
             infection, reports positive SARS-CoV-2 test within 2-10 weeks of enrollment. Not
             excluded: individuals with symptoms consistent with residual sequelae of resolved
             COVID-19, in the clinical judgement of the investigator.

          -  Access to a participating HVTN or HPTN CRS and willingness to be followed for the
             planned duration of the study.

          -  Ability and willingness to provide informed consent.

          -  Assessment of understanding: volunteer demonstrates understanding of this study.

          -  Volunteers who were assigned female sex at birth: negative urine or serum beta human
             chorionic gonadotropin (β-HCG) pregnancy test within 4 days of enrollment visit (ie,
             prior to enrollment blood draw or nasal collections). Persons who are NOT of
             reproductive potential due to having undergone hysterectomy or bilateral oophorectomy
             (verified by medical records) or having reached menopause (no menses for ≥ 1 year ),
             are not required to undergo pregnancy testing.

        Exclusion Criteria:

          -  Reports current COVID-19.

          -  Pregnant.

          -  Receipt of SARS-CoV-2 specific antibodies (eg, convalescent plasma or sera, monoclonal
             antibodies, hyperimmune globulin). Not excluded: antibody therapy without SARS-CoV-2
             specificity (eg, IL-6 pathway inhibitors for COVID-19).

          -  SARS-CoV-2 vaccine(s) received in a prior vaccine trial.

          -  Any medical, psychiatric, occupational, or other condition that, in the judgment of
             the investigator, would interfere with, or serve as a contraindication to, protocol
             adherence or a volunteer's ability to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Larry Corey</last_name>
    <role>Study Chair</role>
    <affiliation>HIV Vaccine Trials Network, Fred Hutch</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shelly Karuna</last_name>
    <role>Study Chair</role>
    <affiliation>HIV Vaccine Trials Network, Fred Hutch</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alabama Vaccine CRS</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>205-934-7349</phone>
      <email>msaag@uab.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>205-996-4405</phone>
      <email>fhoward@uabmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UCLA CARE Center CRS</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>310-825-3782</phone>
      <email>rlandovitz@mednet.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>310-557-9027</phone>
      <email>akhodabakhshian@mednet.ucla.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bridge HIV CRS</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>415-437-7479</phone>
      <email>susan.buchbinder@sfdph.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>415-437-7436</phone>
      <email>theresa.wagner@sfdph.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>George Washington University CRS</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037-1894</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>202-994-3024</phone>
      <email>manyadm@gwu.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>202-480-2344</phone>
      <email>hlyellin@gwu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Ponce de Leon Center CRS</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308-2012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>404-727-1557</phone>
      <email>cdelrio@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>404-616-6313</phone>
      <email>erpatri@emory.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Hope Clinic of the Emory Vaccine Center CRS</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>404-712-1434</phone>
      <email>sedupug@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>404-712-1370</phone>
      <email>shashi.nagar@emory.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Adolescent &amp; Young Adult Research at The CORE Center (AYAR at CORE)</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>312-864-4590</phone>
      <email>toyedele@cookcountyhhs.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>312-572-4571</phone>
      <email>kbojan@cookcountyhhs.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New Orleans Adolescent Trials Unit CRS</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>504-988-3865</phone>
      <email>sabdali@tulane.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>504-988-5348</phone>
      <email>lkozina@tulane.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University CRS</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>443-287-0517</phone>
      <email>kdooley1@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>410-614-4036</phone>
      <email>rbecke22@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital Vaccine CRS (BWH VCRS)</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115-6110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>617-732-6801</phone>
      <email>lbaden@partners.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>617-525-9433</phone>
      <email>jilicona@partners.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Fenway Health Clinical Research Site CRS</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215-4302</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>617-927-6087</phone>
      <email>kmayer@fenwayhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>617-927-6087</phone>
      <email>mgelman@fenwayhealth.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New Jersey Medical School Clinical Research Center CRS</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>973-972-1057</phone>
      <email>swaminsh@njms.rutgers.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>973-972-3729</phone>
      <email>deshierd@njms.rutgers.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bronx Prevention Research Center CRS</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10451</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>212-342-0537</phone>
      <email>jj2158@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>347-590-7280</phone>
      <email>RS2227@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Harlem Prevention Center CRS</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>212-939-2848</phone>
      <email>sbm20@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>646-448-0941</phone>
      <email>al2061@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Columbia P&amp;S CRS</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032-3732</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>212-305-7185</phone>
      <email>mes52@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>212-342-2958</phone>
      <email>sp500@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>New York Blood Center CRS</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>212-570-3081</phone>
      <email>htieu@nybc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>212-388-0008</phone>
      <email>dlucy@nybc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Rochester Vaccines to Prevent HIV Infection CRS</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>585-275-5871</phone>
      <email>michael_keefer@urmc.rochester.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>585-275-5871</phone>
      <email>catherine_bunce@urmc.rochester.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Chapel Hill CRS</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>919-843-2723</phone>
      <email>wohl@med.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coodinator</last_name>
      <phone>919-843-9975</phone>
      <email>bstraub@med.unc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Case CRS</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>216-844-2507</phone>
      <email>br@clevelandactu.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coorindator</last_name>
      <phone>216-844-2546</phone>
      <email>jb@clevelandactu.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Penn Prevention CRS</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>215-746-7346</phone>
      <email>franki@pennmedicine.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>215-746-3713</phone>
      <email>ddunbar@pennmedicine.upenn.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vanderbilt Vaccine CRS</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232-2582</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>615-322-8688</phone>
      <email>spyros.a.kalams@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>E CRS Coordinator</last_name>
      <phone>615-343-6906</phone>
      <email>Shonda.sumner@vumc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Seattle Vaccine and Prevention CRS</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109-1024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>206-667-6704</phone>
      <email>jmcelrat@fhcrc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>206-667-2344</phone>
      <email>dberger@fhcrc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Malawi CRS</name>
      <address>
        <city>Lilongwe</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>265-8614587</phone>
      <email>lchinula@unclilongwe.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>265-1755056</phone>
      <email>tmakuhunga@unclilongwe.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS</name>
      <address>
        <city>Maputo</city>
        <country>Mozambique</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS</name>
      <address>
        <city>Bellavista</city>
        <state>Callao</state>
        <zip>15081</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-997570149</phone>
      <email>jsanchez@citbm.pe</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-1-4800401</phone>
      <phone_ext>1007</phone_ext>
      <email>frosas@citbm.pe</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>San Miguel CRS</name>
      <address>
        <city>San Miguel</city>
        <state>Lima</state>
        <zip>32-15088</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-1-5621600</phone>
      <phone_ext>685</phone_ext>
      <email>pgonzales@impactaperu.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-1-5621600</phone>
      <phone_ext>644</phone_ext>
      <email>msabaduche@impactaperu.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Asociacion Civil Selva Amazonica (ACSA) CRS</name>
      <address>
        <city>Iquitos</city>
        <state>Maynas</state>
        <zip>1</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-65-236277</phone>
      <phone_ext>206</phone_ext>
      <email>mcasapia@acsaperu.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-65-236277</phone>
      <phone_ext>137</phone_ext>
      <email>arimachi@acsaperu.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Via Libra CRS</name>
      <address>
        <city>Lima</city>
        <zip>15001</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-12-039900</phone>
      <phone_ext>110</phone_ext>
      <email>rcabello@vialibre.org.pe</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-12-039900</phone>
      <phone_ext>156</phone_ext>
      <email>canton@vialibre.org.pe</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Barranco CRS</name>
      <address>
        <city>Lima</city>
        <zip>15063</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>51-1-2067800</phone>
      <phone_ext>407</phone_ext>
      <email>jrlama@impactaperu.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>51-1-2067800</phone>
      <phone_ext>209</phone_ext>
      <email>frosas@impactaperu.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Josha Research CRS</name>
      <address>
        <city>Bloemfontein</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-51-4128160</phone>
      <email>josha.research@power4u.co.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-51-4128160</phone>
      <email>louise.verster@josha.co.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Emavundleni CRS</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-21-6505848</phone>
      <email>Lulu.Nair@hiv-research.org.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-21-6505848</phone>
      <email>elaine.sebastian@hiv-research.org.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Groote Schuur HIV CRS</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-21-6506958</phone>
      <email>Catherine.Orrell@hiv-research.org.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-21-6501891</phone>
      <email>Doerieyah.Reynolds@hiv-research.org.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Khayelitsha CRS / (CIDRI UCT)</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-21-4066075</phone>
      <email>graemein@mweb.co.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-21-6501938</phone>
      <email>Rt.goliath@uct.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Masiphumelele Clinical Research Site (MASI) CRS</name>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>+27 (0) 21 406 6966</phone>
      <email>info@hiv-research.org.za</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chatsworth CRS</name>
      <address>
        <city>Chatsworth</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-031-4014150</phone>
      <email>nitesha.jeenarain@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-031-4014150</phone>
      <email>Lakshmi.Baboolall@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Botha's Hill CRS</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-31-7771585</phone>
      <email>Jayganthie.Naidoo@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-031-7771585</phone>
      <email>Ncamsile.Sibisi@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CAPRISA eThekwini CRS</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-31-260-4550</phone>
      <email>nesri.padayatchi@caprisa.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-31-6550658</phone>
      <email>Kieara.Ramtahal@caprisa.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Vulindlela CRS</name>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-31-2604208</phone>
      <email>Quarraisha.abdoolkarim@caprisa.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-33-2606861</phone>
      <email>Hilton.Humphries@caprisa.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Isipingo CRS</name>
      <address>
        <city>Isipingo</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-31-9027494</phone>
      <email>Dishiki.Kalonji@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-31-9027494</phone>
      <email>girisha.kistnasami@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kliptown Soweto CRS</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-11-3424075</phone>
      <email>lazaruse@phru.co.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-11-9899876</phone>
      <email>masalam@phru.co.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Soweto HVTN CRS</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-11-9899700</phone>
      <email>laherf@phru.co.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-11-9899876</phone>
      <email>masalam@phru.co.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Aurum Institute Klerksdorp CRS</name>
      <address>
        <city>Klerksdorp</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-87-135-1587</phone>
      <email>cinnes@auruminstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-87-135-1587</phone>
      <email>tadonis@auruministitute.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Qhakaza Mbokodo Research Clinic CRS</name>
      <address>
        <city>Ladysmith</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-82-4588969</phone>
      <email>plkotze@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-36-6312372</phone>
      <email>michelle01qm@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Nelson Mandela Academic Research Unit CRS</name>
      <address>
        <city>Mthatha</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-083-518407</phone>
      <email>cyasom@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-04-71500012</phone>
      <email>btutshana@witshealth.co.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Synexus Stanza Clinical Research Centre CRS</name>
      <address>
        <city>Pretoria</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-12-9427357</phone>
      <email>sheena.kotze@synexus.com</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-012-8037733</phone>
      <email>Anika.naidoo@synexus.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rustenburg CRS</name>
      <address>
        <city>Rustenburg</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-87-1351575</phone>
      <email>wbrumskine@auruminstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-87-1351587</phone>
      <email>tadonis@auruminstatute.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Setshaba Research Centre CRS</name>
      <address>
        <city>Soshanguve</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-12-7992422</phone>
      <email>kahmed@setshaba.org.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-12-7992422</phone>
      <email>KMapetla@setshaba.org.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tembisa Clinic 4 CRS</name>
      <address>
        <city>Tembisa</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-82-5744541</phone>
      <email>kmngadi@auruminstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-84-4990663</phone>
      <email>yajna@auruminstitute.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Aurum Institute Tembisa Clinical Research Centre CRS</name>
      <address>
        <city>Tembisa</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-87-1351645</phone>
      <email>msebe@auruminstitute.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-87-1351533</phone>
      <email>gkobane@auruminstitute.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Tongaat CRS</name>
      <address>
        <city>Tongaat</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-032-9442208</phone>
      <email>Jayganthie.Naidoo@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-032-9442208</phone>
      <email>Thembisa.Makowa@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Verulam CRS</name>
      <address>
        <city>Verulam</city>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>27-32-5334145</phone>
      <email>Zakir.gaffoor@mrc.ac.za</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>27-32-5334145</phone>
      <email>Mbalenhle.Mbuyisa@mrc.ac.za</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS</name>
      <address>
        <city>Mbeya</city>
        <country>Tanzania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>255-25-2503364</phone>
      <email>nelias@nimr-mmrc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>255-25-2503364</phone>
      <email>lmaganga@nimr-mmrc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Matero Reference Clinic CRS</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>260-95-0693971</phone>
      <email>roma.chilengi@cidrz.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>260-966848889</phone>
      <email>bupe.sichalwe@cidrz.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Zambia Emory HIV Research Project - Lusaka CRS</name>
      <address>
        <city>Lusaka</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>260-96-6862787</phone>
      <email>wkilembe@rzhrg-mail.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>260-96-6862037</phone>
      <email>tsharkey@rzhrg-mail.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Zambia Emory HIV Research Project - Ndola CRS</name>
      <address>
        <city>Ndola</city>
        <country>Zambia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>260-96-6780601</phone>
      <email>minambao@rzhrg-mail.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>260-96-6862037</phone>
      <email>tsharkey@rzhrg-mail.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St Mary's CRS</name>
      <address>
        <city>Chitungwiza</city>
        <country>Zimbabwe</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>263-712-401199</phone>
      <email>tchipato@uzchs-ctrc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>263-772-288160</phone>
      <email>smaonera@uzchs-ctrc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Zengeza CRS</name>
      <address>
        <city>Chitungwiza</city>
        <country>Zimbabwe</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>263-772-264616</phone>
      <email>nmgodi@uzchs-ctrc.org</email>
    </contact>
    <contact_backup>
      <last_name>CRS Coordinator</last_name>
      <phone>263-772-471684</phone>
      <email>pmusara@uzchs-ctrc.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Seke South CRS</name>
      <address>
        <city>Harare</city>
        <country>Zimbabwe</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CRS Leader</last_name>
      <phone>263-774-430144</phone>
      <email>phunidzarira@uzchs-ctrc.org</email>
    </contact>
    <contact_backup>
      <phone>263-24-2701356</phone>
      <email>tchirenda@uzchs-ctrc.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Malawi</country>
    <country>Mozambique</country>
    <country>Peru</country>
    <country>South Africa</country>
    <country>Tanzania</country>
    <country>United States</country>
    <country>Zambia</country>
    <country>Zimbabwe</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 22, 2020</study_first_submitted>
  <study_first_submitted_qc>May 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2020</study_first_posted>
  <last_update_submitted>September 25, 2020</last_update_submitted>
  <last_update_submitted_qc>September 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

